Ensign Peak Advisors’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.09M | Hold |
14,566
| – | – | ﹤0.01% | 1199 |
|
|
2025
Q1 | $926K | Hold |
14,566
| – | – | ﹤0.01% | 1304 |
|
|
2024
Q4 | $1.14M | Hold |
14,566
| – | – | ﹤0.01% | 1242 |
|
|
2024
Q3 | $1.17M | Hold |
14,566
| – | – | ﹤0.01% | 1231 |
|
|
2024
Q2 | $1.21M | Hold |
14,566
| – | – | ﹤0.01% | 1164 |
|
|
2024
Q1 | $1.24M | Sell |
14,566
-735
| -5% | -$62.7K | ﹤0.01% | 1176 |
|
|
2023
Q4 | $1.31M | Buy |
15,301
+950
| +7% | +$81.2K | ﹤0.01% | 1176 |
|
|
2023
Q3 | $1.29M | Hold |
14,351
| – | – | ﹤0.01% | 1019 |
|
|
2023
Q2 | $1.22M | Hold |
14,351
| – | – | ﹤0.01% | 1111 |
|
|
2023
Q1 | $1.19M | Buy |
14,351
+200
| +1% | +$16.6K | ﹤0.01% | 1105 |
|
|
2022
Q4 | $1.11M | Sell |
14,151
-2,500
| -15% | -$197K | ﹤0.01% | 1077 |
|
|
2022
Q3 | $1.23M | Sell |
16,651
-190
| -1% | -$14.1K | ﹤0.01% | 965 |
|
|
2022
Q2 | $1.1M | Hold |
16,841
| – | – | ﹤0.01% | 1072 |
|
|
2022
Q1 | $1.07M | Hold |
16,841
| – | – | ﹤0.01% | 1161 |
|
|
2021
Q4 | $893K | Sell |
16,841
-24,530
| -59% | -$1.3M | ﹤0.01% | 1356 |
|
|
2021
Q3 | $2.92M | Hold |
41,371
| – | – | 0.01% | 897 |
|
|
2021
Q2 | $2.76M | Hold |
41,371
| – | – | 0.01% | 937 |
|
|
2021
Q1 | $4.59M | Sell |
41,371
-9,993
| -19% | -$1.11M | 0.01% | 660 |
|
|
2020
Q4 | $6.1M | Sell |
51,364
-1,300
| -2% | -$154K | 0.01% | 546 |
|
|
2020
Q3 | $4.59M | Hold |
52,664
| – | – | 0.01% | 655 |
|
|
2020
Q2 | $4.72M | Hold |
52,664
| – | – | 0.01% | 622 |
|
|
2020
Q1 | $5.25M | Buy |
52,664
+8,593
| +19% | +$856K | 0.02% | 500 |
|
|
2019
Q4 | $5.06M | Buy |
+44,071
| New | +$5.06M | 0.01% | 640 |
|